Stenograph Announces Phoenix™ Automatic Speech Recognition Engine

Stenograph, LLC, the leader in legal transcription technology, announces Phoenix, an Automatic Speech Recognition (ASR) engine, designed specifically for the court reporting and legal transcription industry to increase productivity and profitability of reporters, court reporting agencies, as well as transcription service providers. Unlike other ASR engines on the market, Phoenix leverages Stenograph’s decades of knowledge of legal terminology, formatting, and editing to provide a solution that is purpose built for the legal industry.

“Stenograph has always led the court reporting and legal transcription industry in innovation to serve the purpose of justice globally,” said Anir Dutta, President of Stenograph. “From the first shorthand machine to the first paperless writer, from audio backup to cloud backup, from RealTeam™ to CaseViewNet®, we have always striven to provide technology that is geared towards enhancing the productivity and profitability for all stakeholders of the court reporting ecosystem. Phoenix is just another step in our journey of continuous innovation. It is a productivity tool which will change the way reporters and agencies produce verbatim transcripts.”

The Phoenix ASR engine will be incorporated into solutions that will support steno, voice, and digital methods with products such as CATalyst™ Proof It, MAXScribe™ Desktop, and CATalyst VP. This is a step towards bridging the increasingly widening gap between supply and demand for quality legal transcripts by improving efficiencies up to 50%. In addition, Stenograph will also provide integrated white label solutions to service providers to incorporate Phoenix into transcription platforms for increasing productivity and profitability of such providers.

“Stenograph is bringing the first custom-built ASR engine to market to support all of our customers and enhance efficiency. It is important to Stenograph that, as the market demands quick turnaround times, high accuracy rates, and more pages being produced more quickly, we continue to innovate to help our customers solve problems,” said Dan Denofsky, Vice President of Marketing. “We are totally dedicated to providing tools that will help customers capture, preserve, and access verbatim records.”

For more information on Stenograph solutions, please visit www.stenograph.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More